Post by HAYA Therapeutics

Happy Transposon Day! 🧬✨ Once considered as mere part of the “junk DNA,” transposable elements (TEs) are now recognized as key drivers of evolutionary innovation—dynamic regulators capable of reshaping gene networks and influencing how cells adapt and respond. This field traces back to Barbara McClintock’s discovery of these “jumping genes” in maize. Her pioneering research was initially met with skepticism for challenging the prevailing idea of a static genome, but was later recognized and honored with the 1983 Nobel Prize in Physiology or Medicine, making her the first woman to receive the award unshared. Today, her work shapes our understanding of the genome as a dynamic system, where non-coding regions play a fundamental role in controlling biological function. At HAYA Therapeutics, we view transposable elements as integral components of the genomic regulatory architecture governing cell identity, fate and behavior. Modulating this portion of the genome holds the potential to induce profound cellular reprogramming, with implications across chronic disease, aging, longevity and healthspan. This exploration is a component of our approach to developing RNA-guided therapeutics that target the Regulatory Genome. ➡️ Explore Dr. McClintock legacy: https://lnkd.in/e2EJe82C Follow our journey for the latest updates on our cell state reprogramming platform as we work to unlock a new frontier in medicine.🧬 #TransposonDay #TE #DNA #Genetics #NobelPrize #Evolution #Innovation #RegulatoryGenome #NonCoding #Biotech #HAYATherapeutics #WomenInScience